about
Systemic Autoimmune, Rheumatic Diseases and Coinciding Psoriasis: Data from a Large Single-Centre Registry and Review of the LiteratureT Helper Cell Subsets in Clinical Manifestations of PsoriasisEffects of coenzyme Q10 supplementation (300 mg/day) on antioxidation and anti-inflammation in coronary artery disease patients during statins therapy: a randomized, placebo-controlled trialEstablishment of an interleukin-1β-induced inflammation-activated endothelial cell-smooth muscle cell-mononuclear cell co-culture model and evaluation of the anti-inflammatory effects of tanshinone IIA on atherosclerosis.Clinico-biochemical correlation between psoriasis and insulin resistanceBeneficial Effects of Coenzyme Q10 Supplementation on Lipid Profile and Intereukin-6 and Intercellular Adhesion Molecule-1 Reduction, Preliminary Results of a Double-blind Trial in Acute Myocardial InfarctionRole of C-reactive protein as a marker of disease severity and cardiovascular risk in patients with psoriasis.Proteome signatures of inflammatory activated primary human peripheral blood mononuclear cells.Improving cardiovascular health and metabolic comorbidities in patients with psoriatic arthritisMolecular and genetic inflammation networks in major human diseases.Psoriasis and Cardiovascular Risk: Assessment by CUORE Project Risk Score in Italian Patients.Loss of Caspase-Activated DNase Protects Against Atherosclerosis in Apolipoprotein E-Deficient Mice.C-reactive protein in psoriasis: a review of the literature.Genetic markers for cardiovascular disease in psoriasis: the missing piece.Prevalence of coronary artery calcification in Japanese patients with psoriasis: A close correlation with bilateral diagonal earlobe creases.The role of dietary fatty acid intake in inflammatory gene expression: a critical review.Thalamic stroke in a young adult with severe psoriasis refractory to adalimumab.Cognitive Impairment in Patients with Psoriasis: A Cross-Sectional Study Using the Montreal Cognitive Assessment.Open questions in autoimmunity: discussions from the 2013 Controversies in Rheumatology and Autoimmunity Meeting.Psoriasis and Cardiovascular Comorbidities: Focusing on Severe Vascular Events, Cardiovascular Risk Factors and Implications for Treatment.Cardiogoniometry in psoriatic patients and its comparison with a control group.Endothelial function is impaired in the cutaneous microcirculation of adults with psoriasis through reductions in nitric oxide-dependent vasodilation.Psoriasis and Cardiovascular Risk: Correlation Between Psoriasis and Cardiovascular Functional Indices.Protective effect of co-administration of rosuvastatin and probucol on atherosclerosis in rats.Metabolic syndrome, C-reactive protein and cardiovascular risk in psoriasis patients: a cross-sectional study.T Cell Hierarchy in the Pathogenesis of Psoriasis and Associated Cardiovascular Comorbidities.Oxidized Low-Density Lipoprotein-Deteriorated Psoriasis Is Associated with the Upregulation of Lox-1 Receptor and Il-23 Expression In Vivo and In Vitro
P2860
Q26785523-CDEA7A1E-B45D-47BF-8A6F-2478006B5EEFQ28069848-9922D45F-1A67-4D03-8BAB-9A60EFE0BE30Q34248508-2F669F38-0E66-4801-BCAD-921301C89C8AQ34474800-0FADAB7B-251F-4E21-90A4-98C3138F035CQ35028089-490115F1-E8A5-4F9B-AAE4-DCF5EE241B55Q35973462-879A36CE-BF4C-4980-9220-0C276FB86F97Q36124545-EBA1DEC6-0393-45E7-BC60-82BD382089BEQ36431688-31CD6BB3-26B2-4436-B2F4-D5BD577D6DB6Q36843650-43D61A38-1CF2-4E25-A004-290E574F1CCEQ37114392-87D5F7DA-F75E-4387-A1D2-753A9E91FE2EQ37191317-7425E855-EDEC-4976-9E9C-48A8B463215AQ37556276-D92D1364-7FF2-4462-ABF1-7362123131FCQ38133614-F54AA7F9-884B-49CC-BFB6-A6467764A845Q38146972-E2EC8BA1-BA1B-4830-8B30-5FB5B3459A72Q38808623-CF936A8A-03A2-4A5A-90AC-F2CED5E688DBQ39079768-BEAC13E3-6A60-4D2E-B56E-77C31286A407Q39554179-43959AE3-CC3A-4EE8-AE8E-57F7D1F005EFQ39898175-88BAC397-60D7-462C-932E-3AB28D0B448AQ42356893-CE7F4BF2-E653-4877-BA4C-DAA1D2DEED44Q46180528-C1120824-E88D-4E56-A228-823D8002A7EDQ47130996-0F42245F-69D1-4C61-BD51-260C3F07EE33Q47750772-4C1B05B2-2E0C-4C7F-B3B8-A18FCB25E910Q48513946-7A875351-60BA-4961-910F-CA989CC22ADAQ53021675-ADFCFD69-1642-4FA2-B208-2BD0AC9D46EBQ55035018-1DBB851D-C8B2-48A4-87F5-FCAF2D4180A7Q55512008-C401486F-7D25-4D42-8640-5315C654F225Q58766510-1B981DF6-FDA2-408C-B462-684AB7C97958
P2860
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Inflammation, atherosclerosis, and psoriasis.
@en
Inflammation, atherosclerosis, and psoriasis.
@nl
type
label
Inflammation, atherosclerosis, and psoriasis.
@en
Inflammation, atherosclerosis, and psoriasis.
@nl
prefLabel
Inflammation, atherosclerosis, and psoriasis.
@en
Inflammation, atherosclerosis, and psoriasis.
@nl
P2093
P2860
P1476
Inflammation, atherosclerosis, and psoriasis
@en
P2093
David Siegel
Ishwarlal Jialal
Siba P Raychaudhuri
Smriti K Raychaudhuri
Sridevi Devaraj
P2860
P2888
P304
P356
10.1007/S12016-012-8308-0
P50
P577
2013-04-01T00:00:00Z